[ad_1]
“It’s a tight window: two days to be tested and another two to receive the drug,” he says. “If you are at home and I think covid is a lie, will you be tested immediately? Because when you are in the hospital, your illness is caused by the body’s response to inflammation and at that time antibiotics do not play a major role.”
In a statement, the World Health Organization believes that “prevention is better than cure” and that “the drug may not be a substitute for vaccines.” The council, based in Geneva, has not yet commented on Paxlovid and says it wants to see if the consequences can be met.
“It will be very difficult to use Paxlovid on a large scale, because people will be tested and treated quickly,” says Robert Shafer, a professor of medicine at Stanford University. “It will not have the same effect as the vaccine can be, and it will be a much more expensive alternative.”
A different approach
Probably so. But pills are still an important addition to the anti-covid army.
At the beginning of the epidemic, international organizations cost billions vaccine programs. He also prioritized “repairing” existing medicines, especially looking for store shelves for anything that could help. But developing new, customized drugs has not received the same treatment as humans. Annette von Delft, a researcher at the University of Oxford, wrote in the book Nature last year, Annette von Delft.
Von Delft is part of an organization called Covid Moonshot that says it is difficult to raise funds to buy new antiretroviral drugs. This is despite the fact that some antiretroviral drugs have been very effective, such as antiretroviral drugs, and more recently, those who overcame hepatitis C. ‘high can take a very long time. .
It is true that such efforts involve a number of unavoidable attempts at trial and error. “You cannot hand a computer an enzyme and say, ‘Make me a medicine to do this. It can give you 100 ideas, but you have to make it, “says Michael Lin, a researcher at Stanford University. real life on animals.
In addition, some major pharmaceutical companies have abandoned strain of virus control in recent years. Although HIV and hepatitis C have prevailed, the list of viruses in rich countries — viruses that have no vaccine and where pills can be made — did not last long. Researchers such as Icahn’s White, a flu-specialist, have found that their performance is reduced. “People didn’t think there were any effective viruses to stop,” White said. “There was a time when it was difficult to stay in business.”
[ad_2]
Source link
